The discrepancies between our results and those in other studies could be attributed to the different ALS pathology that the C9-BAC model represents relative to the SOD1-relevant models, and the different ALS disease stage of C9 mice assessed in our studies relative to those reporting alterations in symptomatic SOD1 mice. Here, C9 is linked to amyotrophic lateral sclerosis.